Cargando…

Pectin in Metabolic Liver Disease

Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wanchao, Cassard, Anne-Marie, Ciocan, Dragos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824118/
https://www.ncbi.nlm.nih.gov/pubmed/36615814
http://dx.doi.org/10.3390/nu15010157
_version_ 1784866330377191424
author Hu, Wanchao
Cassard, Anne-Marie
Ciocan, Dragos
author_facet Hu, Wanchao
Cassard, Anne-Marie
Ciocan, Dragos
author_sort Hu, Wanchao
collection PubMed
description Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota by fecal microbiota transfer or by application of probiotics or prebiotics/fiber in rodent models and human proof-of-concept trials of NAFLD and ALD have demonstrated its possible contribution to reducing the progression of liver damage. In this review, we address the role of a soluble fiber, pectin, in reducing the development of liver injury in NAFLD and ALD through its impact on gut bacteria.
format Online
Article
Text
id pubmed-9824118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98241182023-01-08 Pectin in Metabolic Liver Disease Hu, Wanchao Cassard, Anne-Marie Ciocan, Dragos Nutrients Review Alterations in the composition of the gut microbiota (dysbiosis) are observed in nutritional liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) and have been shown to be associated with the severity of both. Editing the composition of the microbiota by fecal microbiota transfer or by application of probiotics or prebiotics/fiber in rodent models and human proof-of-concept trials of NAFLD and ALD have demonstrated its possible contribution to reducing the progression of liver damage. In this review, we address the role of a soluble fiber, pectin, in reducing the development of liver injury in NAFLD and ALD through its impact on gut bacteria. MDPI 2022-12-29 /pmc/articles/PMC9824118/ /pubmed/36615814 http://dx.doi.org/10.3390/nu15010157 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hu, Wanchao
Cassard, Anne-Marie
Ciocan, Dragos
Pectin in Metabolic Liver Disease
title Pectin in Metabolic Liver Disease
title_full Pectin in Metabolic Liver Disease
title_fullStr Pectin in Metabolic Liver Disease
title_full_unstemmed Pectin in Metabolic Liver Disease
title_short Pectin in Metabolic Liver Disease
title_sort pectin in metabolic liver disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824118/
https://www.ncbi.nlm.nih.gov/pubmed/36615814
http://dx.doi.org/10.3390/nu15010157
work_keys_str_mv AT huwanchao pectininmetabolicliverdisease
AT cassardannemarie pectininmetabolicliverdisease
AT ciocandragos pectininmetabolicliverdisease